| FEMALE REPRODUC TIVE TR AC T MICROB IOTA
The majority of studies on the female reproductive tract microbiome are focused on the vagina because of the ease of sampling; yet, several studies have demonstrated the existence of bacterial colonization beyond the vagina, showing that the upper reproductive tract is not sterile. For example, an active uterine microbiome has been characterized in healthy reproductive-age women, [9] [10] [11] but bacteria have also been found to inhabit the fallopian tubes and the ovaries, 12 with Lactobacillus the most abundant genus throughout the female reproductive tract. 13 Recently, a study surveying the female reproductive tract confirmed the existence of a microbiota continuum starting in the vagina and progressing to the deepest organs in the tract-cervix, uterus, tubes, ovaries, and even colonizing the pouch of Douglas-in women with non-infectious conditions.
| Lower genital tract
The microbiome of the vagina in healthy reproductive-age women presents a biomass of approximately one billion bacteria per gram of vaginal fluid with low diversity, mainly composed of one or few
Lactobacillus species, representing 90%-95% of the total bacteria in the reproductive tract. 14, 15 However, the vaginal microbiota is not dominated by Lactobacillus throughout a woman's lifetime. Indeed, in childhood, anaerobes and Escherichia coli predominate. 16, 17 After puberty, the estrogen rise leads to the production and accumulation of glycogen, which is essential for Lactobacillus growth and the colonization of the vaginal epithelium; the dominance of Lactobacillus is maintained during the reproductive years. Finally, after menopause, the proportion of Lactobacillus species decreases again due to the drop in endogenous estrogen. Interestingly, the Lactobacillus content, as well as a low vaginal pH, is maintained in women receiving hormonal replacement therapy during menopause. [18] [19] [20] The first description of the vaginal microbiome in a set of 396
reproductive-age women using NGS for the 16S rRNA bacterial gene revealed the existence of five distinct community state types (CSTs)
depending on the abundance of the bacteria identified. CST-I, -II, -III, and -V are dominated by Lactobacillus crispatus, Lactobacillus gasserii, Lactobacillus iners, and Lactobacillus jensenii, respectively. 21 The role of Lactobacillus is to maintain vaginal homeostasis by producing lactic acid to lower the vaginal pH. 22, 23 This feature, together with the production of hydrogen peroxide, bacteriocins, and other antimicrobial compounds, facilitates the adhesion of Lactobacilli to the vaginal epithelial cells and competition for the nutrients in the niche to deter the growth of pathogenic bacteria. [24] [25] [26] [27] [28] In contrast, CST-IV is characterized by increased diversity due to polymicrobial colonization with facultative anaerobic bacteria such as Gardnerella, Prevotella, Megasphaera, Atopobium, and Dialister to the detriment of Lactobacilli. 21 Shifts between different CSTs occur in women, sometimes involving acquisition of the CST-IV microbiome. In fact, sexual activity and the transition through CST-IV are risk factors for bacterial vaginosis (BV). 29 However, the CST-IV profile is also common in asymptomatic women depending on their racial background. The percentage of women with a lower genital tract dominated by Lactobacillus is 90%, 80%, 60%, and 60%-37% in White, Asian, Hispanic, and Black populations, respectively. 30 The variation of microbiota profiles in these populations may reflect not only racial or genetic predisposition to one or other types of bacteria, but also geographic, social, and/or economic factors. 30 Among the endogenous factors known to contribute to microbiome changes are hormonal changes during the menstrual cycle. These changes are associated with shifts in vaginal bacterial content, with menses representing the phase in which the microbiome is more diverse, while the oestradiol and progesterone peaks are more bacterially stable times. 31 Some external factors can also modulate the vaginal microbiota, such as hygiene habits, sexual exposure, change of sexual partners, and use and type contraceptives. [31] [32] [33] [34] [35] [36] The factors influencing the structure and composition of the cervicovaginal microbiota were recently reviewed by Kroon and colleagues ( Figure 1 ).
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F I G U R E 1 Factors influencing the composition of the cervicovaginal microbiota. Reprinted from Kroon et al, 37 with permission from Elsevier
| Upper genital tract
Our knowledge about the upper reproductive tract is not as wide, but it is now accepted that the internal organs also harbor a low but active biomass microbiota ( Figure 2 Because it is difficult to obtain samples from the upper genital tract of healthy women, few studies have reported on the "normal" upper reproductive tract microbiome. Using 16S rRNA gene sequencing, the endometrial microbiome of fertile and healthy patients was investigated using minimally invasive methods for the collection of endometrial fluid, and this was compared to vaginal aspirates of the same subjects. This study confirmed that Lactobacillus is the most abundant genus in endometrial samples; Gardnerella, Bifidobacterium, Streptococcus, and Prevotella were also detected, all of which were previously identified in the lower reproductive tract. 10 Further, this study helped to classify the endometrial microbiota profile into Lactobacillus-dominated (LD) and non-Lactobacillus-dominated (NLD) according to the abundance of this bacterial genus (cutoff 90%) and its value to predict reproductive success (see below).
Consistent with previous findings, women usually present similar microbiome profiles in the upper and lower genital tract.
However, 20% of the women in whom the bacterial taxa were identified in endometrial samples showed significant differences in their paired vaginal aspirates. 10 Moreover, this study showed in 22 fertile and asymptomatic donors that the endometrial microbiota is stable during the 5-day period in which endometrial receptivity-the ability to enable embryo implantation-is achieved, between the pre-receptive state (2 days after the LH surge) and the receptive state (7 days after LH peak). 10 These results were corroborated in a study assessing vaginal and endometrial samples of healthy volunteers, non-infertile patients, and patients receiving in vitro fertilization (IVF) treatment in Japan. This study showed that the healthy volunteers presented LD microbiota (≥90% Lactobacillus species), with 25% of the women presenting different taxonomic profiles in endometrial and vaginal samples.
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When healthy volunteers were sampled again in different phases of the cycle or in the consecutive cycle, the microbial profiles were similar, suggesting that the endometrial microbiome may be stable over time. Importantly, however, the sample size was small, and other studies are needed to support this conclusion. 11 The results of these studies support the idea of a microbiota continuum along the reproductive tract and ascension from the vagina as the most plausible mode of upper genital tract colonization, as proposed after G. vaginalis biofilms were found in the fallopian tubes of patients diagnosed with BV. 46 Migration of microorganisms from other organs/tracts to the reproductive tract via hematogenous spreading has also been suggested based on the similarities between the cervical and gastrointestinal tract microbial features in obese patients, or the correspondence between oral and placental microbiota in pregnant women.
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| ROLE OF BAC TERIA IN WOMEN ' S H E A LTH
The upper reproductive tract microbiota is associated with physiology; thus, any unbalance of the microbial composition may impact its functionality, making it a risk factor for many gynecological condi- Ureaplasma species, although yeast can be also involved, 58 to the detriment of the protective LD microbiota. 59 The reported prevalence of this disease in reproductive-age women varies from 8%
to 72%, and it is associated with repeated implantation failure and recurrent pregnancy loss. [58] [59] [60] However, because it is often asymptomatic, it is rarely suspected, diagnosed, and treated. One of the challenges of CE management today is the lack of universally standard criteria for the diagnosis of the disease (ie, number of plasma cells identified per area of screened tissue sections). While the current gold-standard method relies on histopathological identification of plasmacyte infiltrations in the endometrial stroma coupled to CD138 immunohistochemistry, other authors promote hysteroscopic examination of the uterine cavity or the classical culture of endometrial specimens. 58, 60, 61 However, many confounding factors affect the assessment of CE: the method of analysis, the criteria used to discriminate positive and negative samples, the phase of the cycle in which the endometrium is evaluated (ie, the estimated prevalence of CE is approximately 50% higher in endometrial samples collected in the proliferative vs the secretory phase), or even the reagents used in the laboratory developing the test. 60, 62 The most objective of the classical methods is microbial culture, which allows for the isolation of the causing bacteria. Yet, interestingly, the bacteria cultured from endometrial biopsies of CE patients are different from those found in the vagina of the same patients. 63 A comparative study of 65 patients subjected to CE evaluation using the three classical methods-histology/CD138, hysteroscopy, and microbial culture-revealed a poor concordance between methods, resulting in only 20% (13 out of 65) of triple-positive or triple-negative results with all the methods used. 59 Thus, diagnosis of CE depends highly on the method used ( Figure 3) . However, the molecular detection of CE-causing pathogens using targeted PCR or NGS presents a high accuracy (77%) with the results of the three classical methods together and provides information about the identity of those pathogens, even if they are not easy to culture. 59 Thus, the molecular evaluation of CE should be considered in clinical practice because it offers a more objective and reliable diagnostic method to improve clinical management and enable a personalized treatment based on the pathogens identified.
| ROLE OF BAC TERIA IN H UMAN REPRODUC TION
Reproductive tract microbiota at the embryo-maternal interface is receiving increasing attention in human reproduction because it may impact not only the chances of achieving a pregnancy, but also the health status of the mother and the child before and after delivery. The vaginal microbiome of pregnant women who deliver at term is abundant in Lactobacilli, with a significant dominance of CST-I, -II, -III, and -V, whereas high levels of Gardnerella, Ureaplasma, or other bacteria belonging to the CST-IV are often associated with preterm birth and obstetrical complications. [64] [65] [66] [67] [68] [69] On the other hand, the postpartum vaginal microbiome is characterized by a shift to CST-IV even in those pregnancies in which a high Lactobacillus abundance was maintained throughout pregnancy. 69 The dominance of Lactobacillus in the vagina during pregnancy could be explained by the increase in estrogen levels, but it is also hypothesized that this protective microbiome serves as a barrier to prevent the growth of potential pathogens in the fetal membranes and placenta. For this reason, dysbiotic deviations from the LD vaginal profile during pregnancy result in increased risk of miscarriage, premature rupture of membranes, and preterm birth. [70] [71] [72] However, these associations have been mainly reported in White women and could be related to the host background, based on the lack of significant association between BV and preterm birth in Black women. with permission from Elsevier microbiome in low biomass environments to detect and prevent severe obstetrical complications.
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| Role of microbiota in infertility and assisted reproductive technologies (ART)
Evidence from several groups indicates that infertile patients harbor a differential reproductive tract microbiota (lower and/ or upper) compared to healthy and fertile women. 4, [78] [79] [80] Thus, it is worth considering whether IVF outcomes could be influenced by the microbial taxa present in the reproductive tract during infertility treatment. Indeed, deviations from the low-diversity vaginal microbiome, including BV, have been significantly correlated with decreased pregnancy rates after IVF. 81, 82 The association between endometrial dysbiosis and ART failure has long been studied using classical bacterial culture of the tip of the transfer catheter used for embryo transfer. Since the mid-1990s, the isolation of Enterococci,
Enterobacteriaceae (E. coli and Klebsiella pneumoniae), Streptococci,
Staphylococci, and/or Gram-negative bacteria has been correlated with lower implantation and pregnancy rates and increased miscarriage rates, while isolation of Lactobacilli or samples with negative cultures for the aforementioned pathogens has been correlated with better reproductive results. [83] [84] [85] [86] [87] Using the same strategy, the isolation of Streptococcus viridans was significantly correlated to decreased live birth rate, with only 7% of successful pregnancies compared to 88% when Lactobacillus was isolated from the catheter tip at the time of embryo transfer. 85 These studies have now been confirmed using NGS, which is able to characterize the endometrial microbiota at the molecular level in infertile patients with different ART indications: unexplained infertility, repeated implantation failure (RIF), and recurrent pregnancy loss (RPL). 10, 11, 43, 44 The percent composition of Lactobacillus in the endometrium differs between healthy volunteers (85.7%), non-IVF patients (73.9%), and IVF patients (38%), showing that a high percentage of infertile patients subjected to ART present an abnormal endometrial bacterial profile. 11 This is consistent with previous findings showing that 46%
(15/32) of IVF patients with a receptive endometrium presented an NLD microbiota. 10 The first report on the endometrial microbiome's influence on ART using 16S rRNA gene sequencing found that Lactobacillus and Flavobacterium were the most represented genera in the tip of the embryo transfer catheter; however, there was no statistically significant association between the assessed
The abundance of Lactobacilli in endometrial fluid samples is associated with reproductive outcomes in ART patients.
Reprinted from Moreno et al, 10 with permission from Elsevier microbiome and the reproductive outcomes of those patients. 44 Subsequently, the uterine microbiome was investigated by 16S targeted sequencing of endometrial fluid collected from 35 RIF patients with a receptive endometrium. Here, the percentage of Lactobacilli was indeed associated with reproductive outcomes (Figure 4) . NLD microbiota strongly associated with poor reproductive outcomes, compared to patients with LD microbiota, in terms of implantation rate (P = 0.02), pregnancy rate (P = 0.03), ongoing pregnancy (P = 0.02), and live birth rates (P = 0.002). 10 The use of antibiotics has been widely studied to treat BV and prevent preterm birth (reviewed in [ 30, 37 ] 92 The results show that antibiotic therapy is not only effective at eliminating the cause of infection by targeting specific pathogens, but also is useful to ameliorate infertility in RIF patients with CE. Specifically, effective antibiotic therapy against CE improved implantation, clinical pregnancy, ongoing pregnancy, and live birth rates in a subsequent IVF cycle after CE was resolved. Moreover, there were no statistically significant differences in these outcomes between patients with resolved CE and those without CE ( Figure 5 ). These findings suggest that diagnosing and treating CE in RIF patients before embryo transfer could be a useful intervention to eliminate the source of infection, improve the endometrial microbial health, and increase the live birth rates in these patients. 92 Importantly, antibiotic therapy has been also effective in patients with CE and unexplained infertility to increase their chances to conceive spontaneously and maintain a safe pregnancy to term after CE resolution. 
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